The role of ERK2 in colorectal carcinogenesis is partly regulated by TRAPPC4

Molecular Carcinogenesis

Volumn 53, Issue S1, 2014, Pages

  Weng, Yu Rong ^a   Kong, Xuan ^a   Yu, Ya Nan ^a   Wang, Ying Chao ^a   Hong, Jie ^a   Zhao, Shu Liang ^a   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cancer; Cell cycle; Cell proliferation

Indexed keywords

CANCER; CELL CYCLE; CELL PROLIFERATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE TISSUE PROTEINS; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED; VESICULAR TRANSPORT PROTEINS;

EID: 84894458034     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22031     Document Type: Article

References (46)

1. Brenner H, Hoffmeister M, Haug U. Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology. Br J Cancer 2008; 99:532-535.
2. Calvert PM, Frucht H. The genetics of colorectal cancer. Ann Intern Med 2002; 137:603-612.
3. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 2005; 6:322-327.
4. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79:143-180.
5. Wiley HS, Shvartsman SY, Lauffenburger DA. Computational modeling of the EGF-receptor system: A paradigm for systems biology. Trends Cell Biol 2003; 13:43-50.
6. Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR, Kolch W. Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochem J 2005; 392:249-261.
7. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949-954.
8. Hoshino R, Chatani Y, Yamori T, et al. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 1999; 18:813-822.
9. Chen S, Cai H, Park SK, Menon S, Jackson CL, Ferro-Novick S. Trs65p, a subunit of the Ypt1p GEF TRAPPII, interacts with the Arf1p exchange factor Gea2p to facilitate COPI-mediated vesicle traffic. Mol Biol Cell 2011; 22:3634-3644.
10. Brunet S, Noueihed B, Shahrzad N, et al. The SMS domain of Trs23p is responsible for the in vitro appearance of the TRAPP I complex in Saccharomyces cerevisiae. Cell Logist 2012; 2:28-42.
11. Sacher M, Jiang Y, Barrowman J, et al. TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J 1998; 17:2494-2503.
12. Sacher M, Barrowman J, Schieltz D, Yates JR III, Ferro-Novick S. Identification and characterization of five new subunits of TRAPP. Eur J Cell Biol 2000; 79:71-80.
13. Sacher M, Barrowman J, Wang W, et al. TRAPP I implicated in the specificity of tethering in ER-to-Golgi transport. Mol Cell 2001; 7:433-442.
14. Sacher M, Kim YG, Lavie A, Oh BH, Segev N. The TRAPP complex: Insights into its architecture and function. Traffic 2008; 9:2032-2042.
15. Ethell IM, Hagihara K, Miura Y, Irie F, Yamaguchi Y. Synbindin, a novel syndecan-2-binding protein in neuronal dendritic spines. J Cell Biol 2000; 151:53-68.
16. Fan S, Wei Z, Xu H, Gong W. Crystal structure of human synbindin reveals two conformations of longin domain. Biochem Biophys Res Commun 2009; 378:338-343.
17. Chiari R, Foury F, De Plaen E, Baurain JF, Thonnard J, Coulie PG. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene. Cancer Res 1999; 59:5785-5792.
18. Gedeon AK, Colley A, Jamieson R, et al. Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. Nat Genet 1999; 22:400-404.
19. Mochida GH, Mahajnah M, Hill AD, et al. A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly. Am J Hum Genet 2009; 85:897-902.
20. Zhao SL, Hong J, Xie ZQ, et al. TRAPPC4-ERK2 interaction activates ERK1/2, modulates its nuclear localization and regulates proliferation and apoptosis of colorectal cancer cells. PLoS ONE 2011; 6:e23262.
21. Agarwal C, Singh RP, Dhanalakshmi S, et al. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 2003; 22:8271-8282.
22. Li L, Gao Y, Zhang L, Zeng J, He D, Sun Y. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma. Cancer Lett 2008; 272:61-69.
23. Fang JY, Mikovits JA, Bagni R, Petrow-Sadowski CL, Ruscetti FW. Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J Virol 2001; 75:9753-9761.
24. Ji W, Yang J, Wang D, et al. hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers. PLoS ONE 2011; 6:e23274.
25. Mebratu Y, Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle 2009; 8:1168-1175.
26. Iida S, Kato S, Ishiguro M, et al. PIK3CA mutation and methylation influences the outcome of colorectal cancer. Oncol Lett 2012; 3:565-570.
27. Roskoski R, Jr. ERK1/2 MAP kinases: Structure, function, and regulation. Pharmacol Res 2012; 66:105-143.
28. Yoon S, Seger R. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 2006; 24:21-44.
29. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
30. McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007; 1773:1263-1284.
31. Givant-Horwitz V, Davidson B, Lazarovici P, et al. Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions. Gynecol Oncol 2003; 91:160-172.
32. Schmitz KJ, Wohlschlaeger J, Alakus H, et al. Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations. Virchows Arch 2007; 450:151-159.
33. Ji Z, Flaherty KT, Tsao H. Targeting the RAS pathway in melanoma. Trends Mol Med 2012; 18:27-35.
34. Jorgensen K, Holm R, Maelandsmo GM, Flørenes VA. Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: Relationship with clinical outcome. Clin Cancer Res 2003; 9:5325-5331.
35. Cai H, Zhang Y, Pypaert M, Walker L, Ferro-Novick S. Mutants in trs120 disrupt traffic from the early endosome to the late Golgi. J Cell Biol 2005; 171:823-833.
36. Lynch-Day MA, Bhandari D, Menon S, et al. Trs85 directs a Ypt1 GEF, TRAPPIII, to the phagophore to promote autophagy. Proc Natl Acad Sci USA 2010; 107:7811-7816.
37. Meiling-Wesse K, Epple UD, Krick R, et al. Trs85 (Gsg1), a component of the TRAPP complexes, is required for the organization of the preautophagosomal structure during selective autophagy via the Cvt pathway. J Biol Chem 2005; 280:33669-33678.
38. Nazarko TY, Huang J, Nicaud JM, Klionsky DJ, Sibirny AA. Trs85 is required for macroautophagy, pexophagy and cytoplasm to vacuole targeting in Yarrowia lipolytica and Saccharomyces cerevisiae. Autophagy 2005; 1:37-45.
39. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 Repression, mechanisms, and consequences. Cancer Res 2005; 65:3980-3985.
40. Meloche S, Pouysségur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007; 26:3227-3239.
41. Chen CH, Wang WJ, Kuo JC, et al. Tsai HC, Lin JR, Chang ZF, Chen RH, Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J 2005; 24:294-304.
42. Liang Y, Morozova N, Tokarev AA, Mulholland JW, Segev N. The role of Trs65 in the Ypt/Rab guanine nucleotide exchange factor function of the TRAPP II complex. Mol Biol Cell 2007; 18:2533-2541.
43. Cox R, Chen SH, Yoo E, Segev N. Conservation of the TRAPPII-specific subunits of a Ypt/Rab exchanger complex. BMC Evol Biol 2007; 7:12.
44. Morozova N, Liang Y, Tokarev AA, et al. TRAPPII subunits are required for the specificity switch of a Ypt-Rab GEF. Nat Cell Biol 2006; 8:1263-1269.
45. Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocrinol Rev 2001; 22:53-83.
46. Mercer K, Chiloeches A, Huser M, Kiernan M, Marais R, Pritchard C. ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf. Oncogene 2002; 21:347-355.